Consilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum92853Research ArticleMesto mononitratov v lechenii ishemicheskoy bolezni serdtsaNebieridzeD. V-151220081012353828122021Copyright © 2008, Consilium Medicum2008[Bredt D.S. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res 1999; 31 (6): 577–96.][Szocs K. Endothelial dysfunction and reactive oxygen species production in ischemia/reperfusion and nitrate tolerance. Gen Physiol Biophys. 2004; 23 (3): 265–95.][Abrams J. Beneficial actions of nitrates in cardiovascular disease. Am J Cardiol. 1996; 77 (13): 31C–7C.][Abshagen U et al. Pharmacokinetics of intravenous and oral isosorbide-5-mononitrate. Eur J Clin Pharmacol 1981; 20: 269–75.][Abshagen U. Pharmacokinetics of isosorbide mononitrate. Am Cardiol 1992; 70: 61G–66G.][Steudel H.C et al. Pharmacokinetics of isosorbide-5-mononitrate after oral and intravenous administration in patients with liver cirrhosis: first results. Z Kardiol 1983; 72 (suppl. 3): 24–8.][Horowitz J.D. Amelioration of nitrate tolerance: matching strategies with mechanisms. J Am Coll Cardiol. 2003; 41 (11): 2001–3.][Белоусов Ю.Б. Клиническая фармакологитя моночинкве, моночинкве ретард (изосорбида-5-мононитрата).][Lai C et al. A new anti - ischemic drug for the treatment of stable effort angina pectoris: nicorandil. Comparison with placebo and isosorbide-5-mononitrate. Cardiologia 1991; 36: 703–11.][Bayerle A et al. Long - acting, marked antiischemic effect maintained unat - tenuated during long - term interval treatment with once - daily isosorbide-5-mononitrate in sustained release form. Am J Cardiol 1990; 65: 1434–7.][Рекомендации по диагностике и лечению стабильной стенокардии. ВНОК, 2008 г.]